國立高雄大學圖資館 |

Language: English

Back

The mRNA etabolism in human disease

Romao, Luisa.

The mRNA etabolism in human disease

Record Type:	Electronic resources : Monograph/item
Title/Author:	The mRNA etabolism in human diseaseedited by Luisa Romao.
other author:	Romao, Luisa.
Published:	Cham :Springer International Publishing :2019.
Description:	ix, 180 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Medical genetics.
Online resource:	https://doi.org/10.1007/978-3-030-19966-1
ISBN:	9783030199661$q(electronic bk.)

The mRNA etabolism in human disease
The mRNA etabolism in human disease[electronic resource] /edited by Luisa Romao. - Cham :Springer International Publishing :2019. - ix, 180 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v.11570065-2598 ;. - Advances in experimental medicine and biology ;946..

Prelims -- Networks of mRNA processing and alternative splicing regulation in health and disease -- The diverse roles of RNA-binding proteins in glioma development -- Nonsense-mediated mRNA decay in development, stress and cancer -- Implication of mRNA degradation disorders on human DISease: focus on DIS3 and DIS3-like enzymes -- Translational regulation by upstream open reading frames and human diseases -- Alternative mechanisms of mRNA translation initiation in cellular stress response and cancer -- RNA therapeutics: how far have we gone? Index.

The eukaryotic gene expression pathway involves a number of interlinked steps, with messenger RNA (mRNA) being the key intermediate. The precursor mRNA is transcribed from DNA, processed by removal of introns and addition of the cap structure and the poly(A) tail. The mature mRNA is then exported to the cytoplasm where it is translated into protein and finally degraded. In this process, mRNA is associated with RNA-binding proteins forming ribonucleoprotein complexes, whose protein content evolves throughout the lifetime of the mRNA. While the complexity of eukaryotic gene expression allows the production of proteins to be controlled at many levels, it also makes the process vulnerable to errors. Although eukaryotic cells have evolved elaborate mRNA quality control mechanisms that ensure the fidelity of gene expression, some defects are not detected, thus affecting mRNA metabolism. This condition plays a fundamental role in the pathogenesis of several disease processes, such as neurodegeneration and oncogenesis. Besides, exciting recent data have shown that cellular RNAs can be modified post-transcriptionally via dynamic and reversible chemical modifications, the so-called epitranscriptome. These modifications can alter mRNA structure, being able to modulate different steps of the mRNA metabolism that can be associated with various human diseases, such as systemic lupus erythematosus and cancer. This book provides a collection of novel studies and hypotheses aimed to define the pathophysiological consequences of altered mRNA metabolism events in human cells, and is written for a wide spectrum of readers in the field of gene expression regulation. The last chapter highlights how the discovery of disease-causing defects (or modifications) in mRNA can provide a variety of therapeutic targets that can be used for the development of new RNA-based therapeutics. Hopefully, it may also contribute to inspire the drug-developing scientific community.

ISBN: 9783030199661$q(electronic bk.)

Standard No.: 10.1007/978-3-030-19966-1doiSubjects--Topical Terms:

194842
Medical genetics.

LC Class. No.: RB155 / .M763 2019

Dewey Class. No.: 616.042

The mRNA etabolism in human disease
LDR:03577nmm a2200337 a 4500 001 563563
003 DE-He213
005 20191126150954.0
006 m d
007 cr nn 008maaau
008 200311s2019 gw s 0 eng d
020 $a 9783030199661$q(electronic bk.)
020 $a 9783030199654$q(paper)
024 7 $a 10.1007/978-3-030-19966-1 $2 doi
035 $a 978-3-030-19966-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RB155 $b .M763 2019
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
072 7 $a MFN $2 thema
082 0 4 $a 616.042 $2 23
090 $a RB155 $b .M939 2019
245 0 4 $a The mRNA etabolism in human disease $h [electronic resource] / $c edited by Luisa Romao.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a ix, 180 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1157
505 0 $a Prelims -- Networks of mRNA processing and alternative splicing regulation in health and disease -- The diverse roles of RNA-binding proteins in glioma development -- Nonsense-mediated mRNA decay in development, stress and cancer -- Implication of mRNA degradation disorders on human DISease: focus on DIS3 and DIS3-like enzymes -- Translational regulation by upstream open reading frames and human diseases -- Alternative mechanisms of mRNA translation initiation in cellular stress response and cancer -- RNA therapeutics: how far have we gone? Index.
520 $a The eukaryotic gene expression pathway involves a number of interlinked steps, with messenger RNA (mRNA) being the key intermediate. The precursor mRNA is transcribed from DNA, processed by removal of introns and addition of the cap structure and the poly(A) tail. The mature mRNA is then exported to the cytoplasm where it is translated into protein and finally degraded. In this process, mRNA is associated with RNA-binding proteins forming ribonucleoprotein complexes, whose protein content evolves throughout the lifetime of the mRNA. While the complexity of eukaryotic gene expression allows the production of proteins to be controlled at many levels, it also makes the process vulnerable to errors. Although eukaryotic cells have evolved elaborate mRNA quality control mechanisms that ensure the fidelity of gene expression, some defects are not detected, thus affecting mRNA metabolism. This condition plays a fundamental role in the pathogenesis of several disease processes, such as neurodegeneration and oncogenesis. Besides, exciting recent data have shown that cellular RNAs can be modified post-transcriptionally via dynamic and reversible chemical modifications, the so-called epitranscriptome. These modifications can alter mRNA structure, being able to modulate different steps of the mRNA metabolism that can be associated with various human diseases, such as systemic lupus erythematosus and cancer. This book provides a collection of novel studies and hypotheses aimed to define the pathophysiological consequences of altered mRNA metabolism events in human cells, and is written for a wide spectrum of readers in the field of gene expression regulation. The last chapter highlights how the discovery of disease-causing defects (or modifications) in mRNA can provide a variety of therapeutic targets that can be used for the development of new RNA-based therapeutics. Hopefully, it may also contribute to inspire the drug-developing scientific community.
650 0 $a Medical genetics. $3 194842
650 0 $a Genetic regulation. $3 192968
650 0 $a Messenger RNA. $3 277388
650 0 $a RNA $x Metabolism. $3 567068
650 1 4 $a Human Genetics. $3 273658
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Nucleic Acid Chemistry. $3 376665
700 1 $a Romao, Luisa. $3 849194
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-030-19966-1
950 $a Biomedical and Life Sciences (Springer-11642)